97 related articles for article (PubMed ID: 10554568)
21. [Insulin resistance, hypertension and diabetes--value of Metformin and ACE-inhibitors].
Internist (Berl); 1994 Jun; 35(6 Suppl):1-8. PubMed ID: 9131073
[No Abstract] [Full Text] [Related]
22. [Action of metformin at and beyond insulin receptors. Studies in humans].
Joffroy-Lavieuville M; Noël M
Journ Annu Diabetol Hotel Dieu; 1983; ():281-6. PubMed ID: 6358619
[No Abstract] [Full Text] [Related]
23. Metformin.
Crofford OB
N Engl J Med; 1995 Aug; 333(9):588-9. PubMed ID: 7623910
[No Abstract] [Full Text] [Related]
24. [Identification and prevention of vascular risk. Significance of metformin].
Isnard F; André P
Journ Annu Diabetol Hotel Dieu; 1990; ():311-23. PubMed ID: 2195214
[No Abstract] [Full Text] [Related]
25. [Metformin -- biguanid of choice].
Michalak J
Przegl Lek; 1995; 52(1):22-4. PubMed ID: 7784607
[No Abstract] [Full Text] [Related]
26. What your doctor is reading.
Roberts SS
Diabetes Self Manag; 2010; 27(3):48-51. PubMed ID: 20575328
[No Abstract] [Full Text] [Related]
27. [Treatment of type 2 diabetes with metformin].
Amouyal C; Andreelli F
Rev Prat; 2015 Dec; 65(10):1245-9. PubMed ID: 26979012
[No Abstract] [Full Text] [Related]
28. Metformin [Glucophage]: new treatment for NIDDM.
Bihm B; Wilson BA
Medsurg Nurs; 1995 Jun; 4(3):236-8, 254. PubMed ID: 7780481
[No Abstract] [Full Text] [Related]
29. [Update on metformin].
Isnard F
Journ Annu Diabetol Hotel Dieu; 1987; ():323-34. PubMed ID: 3302489
[No Abstract] [Full Text] [Related]
30. Insulin, insulin resistance, obesity, and cancer.
Gallagher EJ; LeRoith D
Curr Diab Rep; 2010 Apr; 10(2):93-100. PubMed ID: 20425567
[TBL] [Abstract][Full Text] [Related]
31. Metformin - a new old drug.
Wróbel MP; Marek B; Kajdaniuk D; Rokicka D; Szymborska-Kajanek A; Strojek K
Endokrynol Pol; 2017; 68(4):482-496. PubMed ID: 28819951
[TBL] [Abstract][Full Text] [Related]
32. [Action of metformin on vascular risk factors in diabetes].
Isnard F; André P; Ibagnez A; Wiernsperger N
Journ Annu Diabetol Hotel Dieu; 1988; ():349-62. PubMed ID: 3050232
[No Abstract] [Full Text] [Related]
33. A novel metformin derivative showed improvement of lipid metabolism in obese rats with type 2 diabetes.
Chen D; Jia D; Wu X; Shi K; Ren C; Dou Y; Guo M; Wang J; Ma M; Wu Z; Shi HY; Li W; Feng Y; Wu F
Clin Exp Pharmacol Physiol; 2020 Aug; 47(8):1382-1392. PubMed ID: 32155673
[TBL] [Abstract][Full Text] [Related]
34. Antiatherogenic properties of metformin: the experimental evidence.
Mamputu JC; Wiernsperger NF; Renier G
Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S71-6. PubMed ID: 14502103
[TBL] [Abstract][Full Text] [Related]
35. [Effect of a single dose of metformin on glucose tolerance in normal and obese patients].
Vague P
Diabete; 1970; 18(1):35-9. PubMed ID: 5509648
[No Abstract] [Full Text] [Related]
36. [Lipoatrophic diabetes with insulin resistance controlled by metformin].
Labeille B; Lalau JD; Chouquais L; Debussche X; Terminassian L; Quichaud J; Denoeux JP
Ann Dermatol Venereol; 1988; 115(11):1151-2. PubMed ID: 3239906
[No Abstract] [Full Text] [Related]
37. Metformin in the treatment of non-insulin-dependent diabetes mellitus.
Saulie B; White J; Campbell RK
Diabetes Educ; 1995; 21(5):441-2, 445. PubMed ID: 7656777
[No Abstract] [Full Text] [Related]
38. Metformin in the treatment of obese diabetics.
Mehrotra TN; Young BA
Br J Clin Pract; 1967 Feb; 21(2):85-6. PubMed ID: 6037937
[No Abstract] [Full Text] [Related]
39. [Operation treatment and medicine treatment of type 2 diabetes mellitus combined with obesity].
Zou DJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov; 12(6):543-4. PubMed ID: 19999273
[No Abstract] [Full Text] [Related]
40. Metformin revisited: its actions and indications for use.
Bailey CJ
Diabet Med; 1988; 5(4):315-20. PubMed ID: 2968877
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
